Literature DB >> 25113898

Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD study.

Aurora Bortoli1, Marco Daperno2, Anna Kohn3, Patrizia Politi4, Stefano Marconi5, Rita Monterubbianesi3, Fabiana Castiglione6, Ada Corbellini7, Manuela Merli8, Giovanni Casella9, Renata D'Incà10, Ambrogio Orlando11, Fabrizio Bossa12, Patrizia Doldo13, Pierenrico Lecis14, Daniela Valpiani15, Silvio Danese16, Michele Comberlato17.   

Abstract

INTRODUCTION: Remarkable differences in quality of care (QoC) might be observed in different countries, affecting quality of life of inflammatory bowel disease (IBD) patients. The aim of this study was to assess patient and physician perceptions of the QoC in Italy.
METHODS: A multicentre observational study on the quality of care in IBD (SOLUTION-1) was conducted in 36 IG-IBD (Italian Group for Inflammatory Bowel Disease) centres in Italy. The QUOTE-IBD (Quality of Care Through the Patient's Eyes) questionnaire was administered to IBD patients and to the attending physicians. The Quality Impact (QI) score summarises the QUOTE-IBD questionnaire, and a QI >9 is considered satisfactory.
RESULTS: Nine-hundred-ninety-two patients and 75 physicians completed the QUOTE-IBD questionnaire. The patients scored the domains of competence (9.47 vs. 8.55) and costs (9.54 vs. 8.26) higher that the physicians, while information (9.31 vs. 9.43) and continuity of care (8.40 vs. 9.01) were scored lower. The QI score was rated worse by physicians with less experience (<12 years) with regard to competence (8.0 vs. 9.01), courtesy (8.12 vs. 10.0) and autonomy (8.97 vs. 10.0). Physicians considered the cost domain unsatisfactory.
CONCLUSIONS: Healthcare was rated as satisfactory overall for Italian patients and physicians. The physicians underestimate their competence and consider the cost of medical management unsatisfactory. The patients are more critical regarding the continuity of care and information. Country-specific data on QoC allow local governments to allocate resources more effectively.
Copyright © 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  QUOTE-IBD; Quality impact score; Quality of care

Mesh:

Year:  2014        PMID: 25113898     DOI: 10.1016/j.crohns.2014.07.004

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  5 in total

1.  Inflammatory bowel disease: Appreciating disability and impact of disease.

Authors:  Subrata Ghosh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-03

2.  Establishing Key Performance Indicators [KPIs] and Their Importance for the Surgical Management of Inflammatory Bowel Disease-Results From a Pan-European, Delphi Consensus Study.

Authors:  Pritesh S Morar; James Hollingshead; Willem Bemelman; Nick Sevdalis; Thomas Pinkney; Graeme Wilson; Malcolm Dunlop; R Justin Davies; Richard Guy; Nicola Fearnhead; Steven Brown; Janindra Warusavitarne; Cathryn Edwards; Omar Faiz
Journal:  J Crohns Colitis       Date:  2017-10-27       Impact factor: 9.071

3.  Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study.

Authors:  Alessandra Guarini; Silvia Biagini; Antonella Capaldi; Daniela Carretto; Anna De Angelis; Salvatore Iudice; Giuseppina Martino; Barbara Marziali; Roberta Mattiola; Cristina Ongarelli; Francesca Maria Onidi; Manuela Prinzio; Reetha Puthiavettil; Romina Sardi; Elisa Schiavoni; Rita Sinatora; Angelo Zullo
Journal:  Ann Gastroenterol       Date:  2016-10-27

4.  Factors Predicting the Adherence to the Therapy of Italian IBD Patients.

Authors:  Cristina Bucci; Fabiana Zingone; Stella Tammaro; Paola Iovino; Antonella Santonicola; Carolina Ciacci
Journal:  Gastroenterol Res Pract       Date:  2017-08-07       Impact factor: 2.260

5.  The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study.

Authors:  Tiziana Larussa; Danilo Flauti; Ludovico Abenavoli; Luigi Boccuto; Evelina Suraci; Raffaella Marasco; Maria Imeneo; Francesco Luzza
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.